Restricted use of Covovax for 12-17 age group

Tribune News Service

Updated At : 11:48 AM Mar 05, 2022 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

New Delhi, March 4

An expert panel of the Drugs Controller General of India (DCGI) on Friday recommended grant of emergency use authorisation to Serum Institute of India’s Covid-19 shot Covovax for 12-17 year olds.

The DCGI had earlier approved Covovax for restricted emergency use in adults on December 28. The vaccine has not been included in the national drive yet. The subject expert committee on Covid of the Central Drugs Standard Control Organisation met today to take up SII’s application and recommended EUA to Covovax in young adolescents. —

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles